ICD-10 Code O28.2: Abnormal cytological finding

Key takeaways

ICD-10 Code O28.2 describes an abnormal cytological finding on antenatal screening of mother, valid and billable for FY2026 (effective October 1, 2025).

Z36 captures the encounter for screening, while O28.2 reports the abnormal cytological result found during that screening.

O28.2 needs no trimester character, and category O28 excludes diagnostic findings that are classified elsewhere.

Documentation must specify the cytological abnormality identified, the clinical context, and the gestational timing to support accurate code assignment.

Practice management software like Pabau captures the structured documentation that supports O28.2 coding, from cytology result to clinical action.

ICD-10 Code O28.2: definition, billable status, and FY2026 validity

ICD-10 Code O28.2 is a billable diagnosis code for an abnormal cytological finding on antenatal screening of mother. It reports the abnormal result found during screening, while a Z36 code reports the screening encounter itself.

O28.2 is a valid ICD-10-CM code for fiscal year 2026. It became effective October 1, 2025, as confirmed by the CDC/NCHS ICD-10-CM web tool. The full official description is: Abnormal cytological finding on antenatal screening of mother.

O28.2 in the ICD-10-CM hierarchy

Knowing where O28.2 sits in the classification tree keeps it apart from adjacent categories. The full hierarchy, as published by CMS, runs from the broad pregnancy chapter down to this specific cytological finding.

Category O28 follows the usual parent-child pattern. The category code is never submitted on its own, and the child codes O28.0 through O28.9 are what appear on a claim. The same block also holds pregnancy complication codes such as O20.0.

Sibling codes under category O28

Category O28 groups all types of abnormal findings from antenatal screening. Each sibling code reflects a different finding type. The table below separates O28.2 from its neighbors when the record holds several screening results.

When one antenatal visit produces both an abnormal cytological result and an abnormal ultrasonic finding, report O28.2 and O28.3 together. Each code covers a distinct finding type, and the same holds for O28.1 when biochemical screening is also abnormal. Once imaging resolves to a named anomaly, code the anomaly itself, such as Q00.2.

Coding guidelines for O28.2 in OB/GYN practice

The includes and excludes notes on category O28 govern how O28.2 interacts with Z36 screening codes. Read them before pairing the two on one claim.

• Includes: Abnormal cytological findings identified during routine antenatal screening of the mother. That covers abnormal cervical smears, or Pap tests, taken as part of prenatal care.
• Excludes1 on category O28: Diagnostic findings classified elsewhere. When a finding carries its own specific code, report that code instead, as with R78.4.
• The reciprocal Z36 note: The screening category Z36 carries an Excludes2 note pointing to O28.-. Both codes can appear on the same claim when the encounter and the finding both apply.
• No trimester character required: Unlike many obstetric codes, O28.2 takes no trimester extension. The code is complete as submitted.
• POA exempt: O28.2 is typically exempt from present on admission (POA) reporting in hospital inpatient settings. Verify against the current CMS POA exempt list for your billing year.

Z36 vs O28.2: which code to use?

Use Z36 when the visit itself is the screening, and O28.2 when the screening returns an abnormal cytological result. Separating encounter type from finding type settles almost every case.

Practices running fertility clinic software with built-in diagnosis code workflows can flag the Z36 versus O28.2 choice while charting. That catches the error before a coder has to fix it.

Documentation requirements for O28.2

ICD-10 Code O28.2 requires documented evidence of the cytological abnormality in the clinical record. A note saying only that antenatal screening was performed will not support it. Four elements carry the code.

• Cytology report reference: The clinical note must reference the laboratory cytology report showing the abnormal finding. The report does not need to be reproduced verbatim, but the note must point to it clearly.
• Nature of the abnormality: Document the type of cytological abnormality identified, such as atypical squamous cells or a low-grade squamous intraepithelial lesion. This specificity supports medical necessity and audit defense.
• Gestational context: Record the gestational age or trimester at the time of the finding. O28.2 takes no trimester extension, but gestational context strengthens the clinical record.
• Clinical decision made: Document the action taken in response to the finding, such as repeat cytology, a colposcopy referral, or watchful waiting. That shows the finding was clinically addressed.

Digital forms structured around antenatal cytology workflows can prompt providers to capture all four elements at the point of care. The coder then works from a recorded answer rather than an inference. Structured medical forms do the same job across other specialties.

Related CPT codes for antenatal cytological screening

O28.2 is a diagnosis code, submitted alongside the CPT codes that describe what was done at the encounter. The table below covers the procedure codes most often billed with it in OB/GYN practice. For reimbursement data, consult the CMS Physician Fee Schedule Look-Up Tool.

Medicare reports a screening Pap with a G code such as G0145, not with the diagnostic cytology codes above. When the visit sits inside the global obstetric package, 59400 already covers the antenatal care itself.

Practices using claims management software can link diagnosis codes to procedure codes at the encounter level, which cuts the risk of mismatched pairings on claims. A properly paired O28.2 and cytology CPT code is less likely to trigger a payer medical necessity query.

ICD-9-CM to ICD-10-CM crosswalk for O28.2

Practices still working with legacy records will run into ICD-9-CM codes. The general equivalence mappings (GEMs) for O28.2 come from the CMS and CDC GEM files. Those files are a US-only product, published for the ICD-9 to ICD-10 transition.

GEM crosswalks are approximate. Confirm any legacy mapping against the official CMS GEM files before it touches an active claim. Reading an ICD-9 code on a record from before October 2015 is one task. Forward-mapping that finding onto a current claim is another.

Present on admission (POA) reporting and O28.2

For hospital inpatient claims, POA reporting separates conditions present at admission from those that developed during the stay. O28.2 sits among the obstetric codes that are exempt from POA indicator requirements.

• POA exempt status: Obstetric diagnosis codes, including O28.2, are generally exempt from POA reporting. They describe maternal conditions tied to the pregnancy rather than hospital-acquired events.
• Inpatient billing: When O28.2 appears on an inpatient claim, no POA indicator is required for it. Verify against the current CMS POA exempt list each year.
• Outpatient settings: POA reporting does not apply to outpatient claims. O28.2 on an office visit claim needs no POA indicator.

HIPAA-compliant documentation applies to every antenatal encounter, inpatient or outpatient. The POA exemption does not reduce what you have to record.

Clinical synonyms that map to O28.2

Multiple clinical terms map to O28.2 in the ICD-10-CM index. Coders searching by clinical description rather than code number will meet these alternate phrasings in documentation, lab reports, and referral letters.

• Abnormal cervical smear in pregnancy
• Abnormal Pap test result during prenatal care
• Abnormal cytology on maternal antenatal screening
• Cytologic abnormality identified on prenatal screening
• Abnormal cervical cytology in pregnancy
• Atypical cervical cells found on antenatal screen

None of these synonyms change the code assignment. If the finding was cytological and turned up during antenatal screening of the mother, O28.2 is correct. The wording in the chart does not change that.

How Pabau supports antenatal screening documentation

Accurate O28.2 coding depends on what gets captured during the encounter itself. Practice management software like Pabau gives maternal health practices structured charting for cytology findings. Pabau’s OB/GYN EMR software then ties each finding to the diagnosis code that supports the claim.

• Structured clinical notes: Pabau Scribe, our AI scribe, records the cytological abnormality, the clinical response, and the gestational context. Coders then read a structured note instead of free text.
• Digital intake and consent forms: Pre-visit forms capture the patient’s antenatal history up front. That makes it easier to tell an O28.2 finding from a routine Z36 encounter.
• Clinical record management: Pabau’s clinical records keep cytology lab reports, encounter notes, and follow-up plans in one place. That is the documentation trail an auditor asks for.
• Compliance workflows: Built-in compliance management holds documentation standards across every antenatal encounter, not only those with abnormal findings.

The result is a chart a coder can work from without a follow-up question. Fewer queries go back to the provider, and fewer antenatal claims come back for rework.

Streamline antenatal screening documentation

Pabau helps OB/GYN and maternal health practices capture structured cytology documentation, link diagnosis codes to procedures, and submit cleaner claims. See how it works for your practice.

Book a demo

Conclusion

The O28.2 decision gets settled at the chart rather than at the claim. If the note names the cytological abnormality and what you did about it, the code follows on its own.

The trade-off worth remembering is specificity. No trimester character is required here, so the weight shifts onto the cytology detail in the note. Build that detail into the form and the code stops being a judgment call.

Pabau’s charting templates and intake forms put those fields in front of the provider during the visit. Book a demo to see how Pabau handles antenatal documentation and claim-ready coding.

Continue your research

Need a prenatal screening record your coders can read? Down syndrome test form sets out the fields a screening record has to carry.

Tracking maternal vitals across the pregnancy? Blood pressure pregnancy chart gives you a printable log for every antenatal visit.

Coding a delivery injury rather than a screening finding? O71.9 explains when unspecified obstetric trauma is the right call.

Billing the global obstetric package after a cesarean? 59510 breaks down what the package includes and what you bill separately.

Releasing cytology results to another provider? HIPAA waiver form covers the clauses that make an authorization valid.

Frequently asked questions